• 13550 Citations
  • 57 h-Index
1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Bonnie S Glisson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Small Cell Lung Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Etoposide Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

38 Citations (Scopus)

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial

Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J. J., Tran, H., Kim, Y. U., Haymaker, C., Bernatchez, C., Curran, M., Zecchini Barrese, T., Rodriguez Canales, J., Wistuba, I., Li, L., Wang, J., Van Der Burg, S. H., Melief, C. J. & 1 others, Glisson, B., Jan 2019, In : JAMA Oncology. 5, 1, p. 67-73 7 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Human papillomavirus 16
Clinical Trials
1 Citation (Scopus)

Correction to: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer (Nature Communications, (2018), 9, 1, (3114), 10.1038/s41467-018-05327-w)

Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L., Yang, L., Lv, J., Guo, Z., Jia, H., Chu, Y., Liu, T., Chen, M., Byers, L., Roarty, E., Lam, V. K., Papadimitrakopoulou, V. A., Wistuba, I., Heymach, J. V., Glisson, B. & 7 others, Liao, Z., Lee, J. J., Futreal, P. A., Zhang, S., Xia, X., Zhang, J. & Wang, J., Dec 1 2019, In : Nature communications. 10, 1, 552.

Research output: Contribution to journalComment/debate

Open Access
document markup languages
Small Cell Lung Carcinoma
3 Citations (Scopus)

Efficacy and safety of rovalpituzumab tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: Results from the phase II TrINITY study

Morgensztern, D., Besse, B., Greillier, L., Santana-Davila, R., Ready, N., Hann, C. L., Glisson, B. S., Farago, A. F., Dowlati, A., Rudin, C. M., Le Moulec, S., Lally, S., Yalamanchili, S., Wolf, J., Govindan, R. & Carbone, D. P., Dec 1 2019, In : Clinical Cancer Research. 25, 23, p. 6958-6966 9 p.

Research output: Contribution to journalArticle

Open Access
Small Cell Lung Carcinoma
delta protein
5 Citations (Scopus)
Drug Approval
Basal Cell Carcinoma
United States Food and Drug Administration
6 Citations (Scopus)

Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma

Amit, M., Abdelmeguid, A. S., Watcherporn, T., Takahashi, H., Tam, S., Bell, D., Ferrarotto, R., Glisson, B., Kupferman, M. E., Roberts, D. B., Su, S. Y., Raza, S. M., DeMonte, F. & Hanna, E. Y., Jan 1 2019, In : Journal of Clinical Oncology. 37, 6, p. 504-512 9 p.

Research output: Contribution to journalArticle

Induction Chemotherapy